The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study
- PMID: 30475988
- DOI: 10.1093/cid/ciy517
The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study
Abstract
Background: Inactivated influenza vaccine (IIV) and pertussis vaccination are recommended in pregnancy. Limited safety data exist for women who received IIV vaccine during the first trimester of pregnancy or received both vaccines in pregnancy. We assessed adverse birth outcomes between vaccinated and unvaccinated pregnancies.
Methods: Among prospectively enrolled Australian "FluMum" participants (2012-2015), primary exposure was receipt and timing of IIV during pregnancy. Primary outcomes included preterm birth, low birthweight at term (LBWT), and small for gestational age (SGA). We compared birth outcomes for IIV in pregnancy with women unvaccinated in pregnancy using Cox proportional hazard ratios (HRs) with 95% confidence intervals (CIs). Adjusted HRs (aHRs) controlled for potential confounding variables. Sensitivity analyses were conducted in a subgroup of women who received pertussis vaccination during pregnancy to assess whether associations between IIV and adverse outcomes were maintained after adjusting for pertussis vaccination.
Results: Among 8827 participants in our study, women who received IIV in pregnancy did not have an elevated risk of an adverse birth outcome compared with unvaccinated pregnant women: preterm births (HR, 1.10 [95% CI, .92-1.31]; P = .28); LBWT (HR, 1.05 [95% CI, .76-1.44]; P = .77); or SGA (HR, 0.99 [95% CI, .86-1.15]; P = .94). Adjustment for pertussis vaccination during pregnancy yielded similar results: preterm births (aHR, 1.05 [95% CI, .82-1.34]; P = .69); LBWT (aHR, 0.81 [95% CI, .50-1.29]; P = .37); SGA (aHR, 0.92 [95% CI, .74-1.14]; P = .43). There was no evidence of elevated risk by trimester of IIV.
Conclusions: No significant associations were found between maternal IIV or pertussis vaccination in pregnancy and adverse birth outcomes, regardless of the trimester of pregnancy a vaccination was given compared to unvaccinated pregnancies.
Similar articles
-
Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.Vaccine. 2017 Mar 7;35(10):1403-1409. doi: 10.1016/j.vaccine.2017.01.075. Epub 2017 Feb 9. Vaccine. 2017. PMID: 28190746
-
Baseline incidence of adverse birth outcomes and infant influenza and pertussis hospitalisations prior to the introduction of influenza and pertussis vaccination in pregnancy: a data linkage study of 78 382 mother-infant pairs, Northern Territory, Australia, 1994-2015.Epidemiol Infect. 2019 Jan;147:e233. doi: 10.1017/S0950268819001171. Epidemiol Infect. 2019. PMID: 31364572 Free PMC article.
-
'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women.BMJ Open. 2019 Jun 20;9(6):e030277. doi: 10.1136/bmjopen-2019-030277. BMJ Open. 2019. PMID: 31227542 Free PMC article.
-
The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis.Am J Perinatol. 2016 Sep;33(11):1104-14. doi: 10.1055/s-0036-1586101. Epub 2016 Sep 7. Am J Perinatol. 2016. PMID: 27603545 Review.
-
Experience and challenges on influenza and pertussis vaccination in pregnant women.Hum Vaccin Immunother. 2018;14(9):2183-2188. doi: 10.1080/21645515.2018.1483810. Epub 2018 Jul 24. Hum Vaccin Immunother. 2018. PMID: 30024822 Free PMC article. Review.
Cited by
-
Safety of influenza vaccination during pregnancy: a systematic review.BMJ Open. 2023 Sep 6;13(9):e066182. doi: 10.1136/bmjopen-2022-066182. BMJ Open. 2023. PMID: 37673449 Free PMC article.
-
Safety and Protective Effects of Influenza Vaccination in Pregnant Women on Pregnancy and Birth Outcomes in Pune, India: A Cross-Sectional Study.Vaccines (Basel). 2023 May 28;11(6):1034. doi: 10.3390/vaccines11061034. Vaccines (Basel). 2023. PMID: 37376423 Free PMC article.
-
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis.Vaccine. 2023 Jun 7;41(25):3688-3700. doi: 10.1016/j.vaccine.2023.03.038. Epub 2023 Mar 27. Vaccine. 2023. PMID: 37012114 Free PMC article. Review.
-
Perspectives on administration of COVID-19 vaccine to pregnant and lactating women: a challenge for low- and middle-income countries.AJOG Glob Rep. 2021 Nov;1(4):100020. doi: 10.1016/j.xagr.2021.100020. Epub 2021 Sep 3. AJOG Glob Rep. 2021. PMID: 34494014 Free PMC article.
-
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.Vaccine. 2021 Sep 24;39(40):5891-5908. doi: 10.1016/j.vaccine.2021.08.034. Epub 2021 Aug 13. Vaccine. 2021. PMID: 34489131 Free PMC article. Review.